Neogen (NEOG) Interest & Investment Income (2010 - 2025)
Neogen's (NEOG) quarterly Interest & Investment Income came in at $592000.0 in Q4 2025, down 23.51% year-on-year from $774000.0 in Q4 2024, and down 35.51% quarter-over-quarter from $918000.0 in Q3 2025.
Neogen (NEOG) Interest & Investment Income (2010 - 2025) Analysis & Trends
Neogen's Interest & Investment Income history runs 14 years deep, the most recent figure standing at $592000.0 for Q4 2025.
- On a quarterly basis, Interest & Investment Income fell 23.51% year-over-year to $592000.0 in Q4 2025; TTM through Nov 2025 was $2.9 million, a 36.26% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, down 51.12% from the prior year.
- Interest & Investment Income declined to $592000.0 in Q4 2025 per NEOG's latest filing, from $918000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.9 million in Q4 2023 and bottomed at $246000.0 in Q4 2021.
- The 5-year median for Interest & Investment Income is $846000.0 (2024), against an average of $921500.0.
- Across the five-year window, Interest & Investment Income jumped 236.89% in 2023 and slumped 58.45% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $246000.0 in 2021, then surged by 124.8% to $553000.0 in 2022, then soared by 236.89% to $1.9 million in 2023, then slumped by 58.45% to $774000.0 in 2024, then fell by 23.51% to $592000.0 in 2025.
- Per Business Quant, the three latest NEOG Interest & Investment Income figures stand at $592000.0 (Q4 2025), $918000.0 (Q3 2025), and $644000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 592,000.00 |
| Aug 31, 2025 | 918,000.00 |
| May 31, 2025 | 644,000.00 |
| Feb 28, 2025 | 699,000.00 |
| Nov 30, 2024 | 774,000.00 |
| Aug 31, 2024 | 993,000.00 |
| May 31, 2024 | 1.10 Mn |
| Feb 29, 2024 | 1.61 Mn |
| Nov 30, 2023 | 1.86 Mn |
| Aug 31, 2023 | 1.79 Mn |
| May 31, 2023 | 1.00 Mn |
| Feb 28, 2023 | 640,000.00 |
| Nov 30, 2022 | 553,000.00 |
| Aug 31, 2022 | 971,000.00 |
| Feb 28, 2022 | 349,000.00 |
| Nov 30, 2021 | 246,000.00 |
| Feb 28, 2018 | 524,000.00 |
| Nov 30, 2017 | 429,000.00 |
| Aug 31, 2017 | 369,000.00 |
| May 31, 2017 | 148,000.00 |